HyperaFRA:HM6A -1.12%92 OCF Margin % is 25.81% as of Mar. 2026, which is 8% below its 10-year median of 27.98. GuruFocus rates FRA:HM6A with a GF Score™ of 92/100 and a GF Value™ of €5.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, Hypera ranks better than 92.36% on this metric.
The historical rank and industry rank for Hypera's OCF Margin % or its related term are showing as below:
FRA:HM6A'
s OCF Margin % Range Over the Past 10 Years
Min: 23.56 Med: 27.98 Max: 34.12
Current: 29.23
During the past 13 years, the highest OCF Margin % of Hypera was 34.12%. The lowest was 23.56%. And the median was 27.98%.
FRA:HM6A's OCF Margin % is ranked better than 92.36% of 956
companies
in the Drug Manufacturers industry
Industry Median: 9.985
vs FRA:HM6A: 29.23
Hypera OCF Margin % Related Terms
Hypera OCF Margin % Historical Data
* Premium members only.
The historical data trend for Hypera's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HM6A vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hypera OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hypera's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Hypera's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypera (FRA:HM6A) has a OCF Margin % of 25.81% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hypera and its competitors. This is near median its historical median of 27.98. Over the past decade, Hypera's OCF Margin % has ranged from 23.56 to 34.12. According to the industry distribution chart, Hypera ranks #73 out of 956 companies in the Drug Manufacturers industry, placing it in the top 7.6%.
Is Hypera's OCF Margin % too high?
Hypera's current OCF Margin % of 25.81% is near median its 10-year median of 27.98. Over the past 10 years, this metric has ranged from a low of 23.56 to a high of 34.12. The Drug Manufacturers industry median OCF Margin % is 9.99. Hypera's value of 25.81% is 158.5% above this industry median. Based on the distribution chart, Hypera ranks #73 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hypera has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hypera's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hypera ranks #73 out of 956 companies for OCF Margin %. This places Hypera in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Hypera's value of 25.81% is 158.5% above this benchmark. Historically, Hypera's own OCF Margin % has ranged from 23.56 to 34.12 over the past decade. While the company's 10-year median is 27.98 vs. the industry median of 9.99, Hypera has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hypera's current OCF Margin % of 25.81% is 158.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hypera and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypera's current OCF Margin % is 25.81%, which is near median its own 10-year median of 27.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypera stock overvalued right now?
Based on GuruFocus' analysis, Hypera (FRA:HM6A) is currently considered Possible Value Trap. The stock's GF Value™ is €5.23, compared to a current price of €3.54 — trading 32.3% below its estimated fair value. The current OCF Margin % is 25.81%, which is near median its 10-year median of 27.98 and 158.5% above the Drug Manufacturers industry median of 9.99. Hypera's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hypera (FRA:HM6A), the current OCF Margin % is 25.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hypera (FRA:HM6A) Overvalued in 2026?
Based on GuruFocus' analysis, Hypera stock appears to be undervalued.
The current stock price of €3.54 is trading 32.3% below its estimated GF Value™ of €5.23.
GuruFocus considers Hypera to be Possible Value Trap.
Key valuation signals for FRA:HM6A:
OCF Margin %: 25.81% (near median its 10-year median of 27.98)
GF Value™: €5.23 vs. price of €3.54 (32.3% below fair value)
Industry Position: 158.5% above the Drug Manufacturers median (#73 of 956)
No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
92GF Score
Get the complete analysis for FRA:HM6A
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HM6A has been successfully added to your 
